Global Clinical Trial Market Growth (Status and Outlook) 2025-2031

Global Clinical Trial Market Growth (Status and Outlook) 2025-2031

The global Clinical Trial market size is predicted to grow from US$ 53980 million in 2025 to US$ 91170 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is "safe" or effective, only that the trial may be conducted.

The industry"s leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.

LPI (LP Information)' newest research report, the “Clinical Trial Industry Forecast” looks at past sales and reviews total world Clinical Trial sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Trial sales for 2025 through 2031. With Clinical Trial sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial industry.

This Insight Report provides a comprehensive analysis of the global Clinical Trial landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial market by product type, application, key players and key regions and countries.

Segmentation by Type:
Instruments(Products)
Consumables
Others

Segmentation by Application:
Procurement and Supplies
Rentals
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
PRA Health
LabCorp (Covance)
Marken
AmerisourceBergen (World Courier)